These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4337525)

  • 21. Studies on the antiviral activity of amantadine hydrochloride.
    Cochran KW; Maassab HF; Tsunoda A; Berlin BS
    Ann N Y Acad Sci; 1965 Jul; 130(1):432-9. PubMed ID: 4285587
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir.
    Bantia S; Parker CD; Ananth SL; Horn LL; Andries K; Chand P; Kotian PL; Dehghani A; El-Kattan Y; Lin T; Hutchison TL; Montgomery JA; Kellog DL; Babu YS
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1162-7. PubMed ID: 11257030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ammonium chloride and viral penetration.
    Eaton MD; Scala AR
    Arch Gesamte Virusforsch; 1967; 20(4):411-20. PubMed ID: 5598022
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants.
    Gubareva LV; Webster RG; Hayden FG
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3403-8. PubMed ID: 11709315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in pharmacology. New treatments for influenza: neuraminidase inhibitors.
    Cross J; Wedekind CA
    Med Health R I; 2001 Jun; 84(6):209-11. PubMed ID: 11434154
    [No Abstract]   [Full Text] [Related]  

  • 26. [An attempt at direct proof of the enzymatic (neuraminidase) nature of the process of "unmasking" hidden influenza A2 virus hemagglutinin].
    Tsvetkova IV; Lipkind MA
    Vopr Virusol; 1970; 15(4):409-14. PubMed ID: 5505402
    [No Abstract]   [Full Text] [Related]  

  • 27. [Neuraminidase inhibitors resistance in influenza viruses and the related mechanisms].
    Huang L; Zhou JF; Wei H; Shu YL
    Bing Du Xue Bao; 2012 Sep; 28(5):572-6. PubMed ID: 23233936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic effect of zanamivir-porphyrin conjugates on inhibition of neuraminidase and inactivation of influenza virus.
    Wen WH; Lin M; Su CY; Wang SY; Cheng YS; Fang JM; Wong CH
    J Med Chem; 2009 Aug; 52(15):4903-10. PubMed ID: 19522501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design.
    Chand P; Babu YS; Bantia S; Chu N; Cole LB; Kotian PL; Laver WG; Montgomery JA; Pathak VP; Petty SL; Shrout DP; Walsh DA; Walsh GM
    J Med Chem; 1997 Dec; 40(25):4030-52. PubMed ID: 9406595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimation of the number of surface projections on myxo- and paramyxoviruses.
    Tiffany JM; Blough HA
    Virology; 1970 Jun; 41(2):392-4. PubMed ID: 5422728
    [No Abstract]   [Full Text] [Related]  

  • 31. Influenza virus neuraminidase inhibitors.
    Gubareva LV; Kaiser L; Hayden FG
    Lancet; 2000 Mar; 355(9206):827-35. PubMed ID: 10711940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance to neuraminidase inhibitors.
    Dolin R
    Clin Infect Dis; 2011 Feb; 52(4):438-9. PubMed ID: 21248366
    [No Abstract]   [Full Text] [Related]  

  • 33. Interactions of concanavalin A with the membrane of infleunza virus infected cells and with envelope components of the virus particle.
    Rott R; Becht H; Klenk HD; Scholtissek C
    Z Naturforsch B Anorg Chem Org Chem Biochem Biophys Biol; 1972 Mar; 27(3):227-33. PubMed ID: 4402622
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of the neuraminidases of three avian paramyxoviruses.
    Alexander DJ
    Arch Gesamte Virusforsch; 1974; 44(1):28-34. PubMed ID: 4363044
    [No Abstract]   [Full Text] [Related]  

  • 35. Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity.
    Kim JH; Resende R; Wennekes T; Chen HM; Bance N; Buchini S; Watts AG; Pilling P; Streltsov VA; Petric M; Liggins R; Barrett S; McKimm-Breschkin JL; Niikura M; Withers SG
    Science; 2013 Apr; 340(6128):71-5. PubMed ID: 23429702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the receptor of influenza viruses. 1. Artificial receptor for influenza virus.
    Huang RT; Rott R; Klenk HD
    Z Naturforsch C; 1973; 28(5):342-5. PubMed ID: 4358675
    [No Abstract]   [Full Text] [Related]  

  • 37. Disruption of myxoviruses with Tween 20 and isolation of biologically active hemagglutinin and neuraminidase subunits.
    Webster RG; Darlington RW
    J Virol; 1969 Aug; 4(2):182-7. PubMed ID: 5806984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011-2012 season in Japan.
    Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
    J Infect Chemother; 2014 Feb; 20(2):77-80. PubMed ID: 24560563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of influenza viruses in vitro and in vivo by 1-adamantanamine hydrochloride.
    Schild GC; Sutton RN
    Br J Exp Pathol; 1965 Jun; 46(3):263-73. PubMed ID: 4284028
    [No Abstract]   [Full Text] [Related]  

  • 40. A designer drug against influenza: the NA inhibitor oseltamivir (Tamiflu).
    Oxford JS; Mann A; Lambkin R
    Expert Rev Anti Infect Ther; 2003 Aug; 1(2):337-42. PubMed ID: 15482128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.